Radiomic signature: A novel magnetic resonance imaging-based prognostic biomarker in patients with skull base chordoma

Wei, Wei; Wang, Ke; Liu, Zhenyu; Tian, Kaibing; Wang, Liang; Du, Jiang; Ma, Junpeng; Wang, Shuo; Li, Longfei; Zhao, Rui; Cui, Luo; Wu, Zhen; Tian, Jie

doi:10.1016/j.radonc.2019.10.002

Title: Radiomic signature: A novel magnetic resonance imaging-based prognostic biomarker in patients with skull base chordoma

Full Record
Other Related Research

Authors:

; Wang, Ke;

; Tian, Kaibing; Wang, Liang; Du, Jiang; Ma, Junpeng; Wang, Shuo; Li, Longfei; Zhao, Rui; Cui, Luo; Wu, Zhen; Tian, Jie

Publication Date:: Sun Dec 01 00:00:00 EST 2019

Sponsoring Org.:: USDOE Office of Electricity (OE), Advanced Grid Research & Development. Power Systems Engineering Research

OSTI Identifier:: 1693728

Grant/Contract Number:: 2017YFA0205200; 2016YFA0100900; 2016YFA0100902

Resource Type:: Publisher's Accepted Manuscript

Journal Name:: Radiotherapy and Oncology

Additional Journal Information:: Journal Name: Radiotherapy and Oncology Journal Volume: 141 Journal Issue: C; Journal ID: ISSN 0167-8140

Publisher:: Elsevier

Country of Publication:: Netherlands

Language:: English

Citation Formats


                    Wei, Wei, Wang, Ke, Liu, Zhenyu, Tian, Kaibing, Wang, Liang, Du, Jiang, Ma, Junpeng, Wang, Shuo, Li, Longfei, Zhao, Rui, Cui, Luo, Wu, Zhen, and Tian, Jie. Radiomic signature: A novel magnetic resonance imaging-based prognostic biomarker in patients with skull base chordoma.  Netherlands: N. p., 2019. 
Web.  doi:10.1016/j.radonc.2019.10.002.

Copy to clipboard


                    Wei, Wei, Wang, Ke, Liu, Zhenyu, Tian, Kaibing, Wang, Liang, Du, Jiang, Ma, Junpeng, Wang, Shuo, Li, Longfei, Zhao, Rui, Cui, Luo, Wu, Zhen, & Tian, Jie. Radiomic signature: A novel magnetic resonance imaging-based prognostic biomarker in patients with skull base chordoma.  Netherlands.  https://doi.org/10.1016/j.radonc.2019.10.002

Copy to clipboard


                    Wei, Wei, Wang, Ke, Liu, Zhenyu, Tian, Kaibing, Wang, Liang, Du, Jiang, Ma, Junpeng, Wang, Shuo, Li, Longfei, Zhao, Rui, Cui, Luo, Wu, Zhen, and Tian, Jie. Sun .  
"Radiomic signature: A novel magnetic resonance imaging-based prognostic biomarker in patients with skull base chordoma".  Netherlands.  https://doi.org/10.1016/j.radonc.2019.10.002.

Copy to clipboard


                    
@article{osti_1693728,

  title        = {Radiomic signature: A novel magnetic resonance imaging-based prognostic biomarker in patients with skull base chordoma},

  author       = {Wei, Wei and Wang, Ke and Liu, Zhenyu and Tian, Kaibing and Wang, Liang and Du, Jiang and Ma, Junpeng and Wang, Shuo and Li, Longfei and Zhao, Rui and Cui, Luo and Wu, Zhen and Tian, Jie},

  abstractNote = {},

  doi          = {10.1016/j.radonc.2019.10.002},

  journal      = {Radiotherapy and Oncology},

  number       = C,

  volume       = 141,

  place        = {Netherlands},

  year         = {Sun Dec 01 00:00:00 EST 2019},

  month        = {Sun Dec 01 00:00:00 EST 2019}

}

Copy to clipboard

Journal Article:

Free Publicly Available Full Text

Accepted Manuscript (Publisher)

Publisher's Version of Record
https://doi.org/10.1016/j.radonc.2019.10.002

Other availability

Search WorldCat to find libraries that may hold this journal

Save / Share:

Export Metadata

Save to My Library

Similar Records in DOE PAGES and OSTI.GOV collections:

TU-CD-BRB-08: Radiomic Analysis of FDG-PET Identifies Novel Prognostic Imaging Biomarkers in Locally Advanced Pancreatic Cancer Patients Treated with SBRT

Journal Article Cui, Y ; Shirato, H ; Song, J ; ... - Medical Physics

Purpose: This study aims to identify novel prognostic imaging biomarkers in locally advanced pancreatic cancer (LAPC) using quantitative, high-throughput image analysis. Methods: 86 patients with LAPC receiving chemotherapy followed by SBRT were retrospectively studied. All patients had a baseline FDG-PET scan prior to SBRT. For each patient, we extracted 435 PET imaging features of five types: statistical, morphological, textural, histogram, and wavelet. These features went through redundancy checks, robustness analysis, as well as a prescreening process based on their concordance indices with respect to the relevant outcomes. We then performed principle component analysis on the remaining features (number ranged frommore »« less
https://doi.org/10.1118/1.4925593
Quantitative Analysis of {sup 18}F-Fluorodeoxyglucose Positron Emission Tomography Identifies Novel Prognostic Imaging Biomarkers in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy

Journal Article Cui, Yi ; Global Institution for Collaborative Research and Education, Hokkaido University, Sapporo ; Song, Jie ; ... - International Journal of Radiation Oncology, Biology and Physics

Purpose: To identify prognostic biomarkers in pancreatic cancer using high-throughput quantitative image analysis. Methods and Materials: In this institutional review board–approved study, we retrospectively analyzed images and outcomes for 139 locally advanced pancreatic cancer patients treated with stereotactic body radiation therapy (SBRT). The overall population was split into a training cohort (n=90) and a validation cohort (n=49) according to the time of treatment. We extracted quantitative imaging characteristics from pre-SBRT {sup 18}F-fluorodeoxyglucose positron emission tomography, including statistical, morphologic, and texture features. A Cox proportional hazard regression model was built to predict overall survival (OS) in the training cohort using 162more »« less
https://doi.org/10.1016/J.IJROBP.2016.04.034
SU-F-R-24: Identifying Prognostic Imaging Biomarkers in Early Stage Lung Cancer Using Radiomics

Journal Article Zeng, X ; Wu, J ; Cui, Y ; ... - Medical Physics

Purpose: Patients diagnosed with early stage lung cancer have favorable outcomes when treated with surgery or stereotactic radiotherapy. However, a significant proportion (∼20%) of patients will develop metastatic disease and eventually die of the disease. The purpose of this work is to identify quantitative imaging biomarkers from CT for predicting overall survival in early stage lung cancer. Methods: In this institutional review board-approved HIPPA-compliant retrospective study, we retrospectively analyzed the diagnostic CT scans of 110 patients with early stage lung cancer. Data from 70 patients were used for training/discovery purposes, while those of remaining 40 patients were used for independentmore »« less
https://doi.org/10.1118/1.4955796
Positron Emission Tomography/Computed Tomography Imaging of Residual Skull Base Chordoma Before Radiotherapy Using Fluoromisonidazole and Fluorodeoxyglucose: Potential Consequences for Dose Painting

Journal Article Mammar, Hamid ; CNRS-UMR 6543, Institute of Developmental Biology and Cancer, University of Nice Sophia Antipolis, Nice ; Kerrou, Khaldoun ; ... - International Journal of Radiation Oncology, Biology and Physics

Purpose: To detect the presence of hypoxic tissue, which is known to increase the radioresistant phenotype, by its uptake of fluoromisonidazole (18F) (FMISO) using hybrid positron emission tomography/computed tomography (PET/CT) imaging, and to compare it with the glucose-avid tumor tissue imaged with fluorodeoxyglucose (18F) (FDG), in residual postsurgical skull base chordoma scheduled for radiotherapy. Patients and Methods: Seven patients with incompletely resected skull base chordomas were planned for high-dose radiotherapy (dose {>=}70 Gy). All 7 patients underwent FDG and FMISO PET/CT. Images were analyzed qualitatively by visual examination and semiquantitatively by computing the ratio of the maximal standardized uptake valuemore »« less
https://doi.org/10.1016/J.IJROBP.2011.12.047
State-of-the-Art Imaging in Human Chordoma of the Skull Base

Journal Article Santegoeds, Rene G. C., ; Temel, Yasin ; Beckervordersandforth, Jan C. ; ... - Current Radiology Reports

Purpose of Review: Chordoma are rare tumours of the axial skeleton which occur most often at the base of the skull and in the sacrum. Although chordoma are generally slow-growing lesions, the recurrence rate is high and the location makes it often difficult to treat. Both computed tomography (CT) and magnetic resonance imaging (MRI) are crucial in the initial diagnosis, treatment planning and post-treatment follow-up. Recent Findings: Basic MRI and CT characteristics of chordoma were described in the late 1980s and early 1990s. Since then, imaging techniques have evolved with increased resolution and new molecular imaging tools are rapidly evolving. Newmore »« less
https://doi.org/10.1007/S40134-018-0275-7

Similar Records